Somatic mutations in the skin not responsible for the start or spread of psoriasis

An FDA ad­vi­so­ry com­mit­tee vot­ed against back­ing Lykos Ther­a­peu­tics’ MD­MA-based ther­a­py for post-trau­mat­ic stress dis­or­der, a blow to the biotech com­pa­ny’s ef­forts to bring the

Years of Alzheimer’s set­backs have not dis­suad­ed Roche from go­ing af­ter one of the most chal­leng­ing R&D fields, and new da­ta in­di­cate how its con­tin­ued